Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment interruptions news

Show

From To
Barriers to care: immigration removal centres and HIV

Evidence has shown that a series of failings in immigration removal centres (IRCs) has compromised the continuity of care for people with HIV. Guest writer Daniel Lombard investigates.

Published
13 October 2011
From
HIV treatment update
Treatment breaks lead to fibrosis in HIV/HCV-co-infected patients

Interrupting HIV therapy is associated with the progression of liver damage in patients co-infected with HIV and hepatitis C, Canadian investigators report in the online edition of

Published
07 April 2011
By
Michael Carter
Ivory Coast doctor warns hundreds more will die if they can't get HIV treatment

“The situation is very serious. Our programmes are suspended because of the violence. We are very worried that although some HIV treatment is available, supplies will run out in the next 2-3 weeks unless new supplies of medicines are able to be got into the country."

Published
06 April 2011
From
Reuters AlertNet
Stigma forces many to leave ART midway: Expert

HIV patients on antiretroviral treatment (ART) leaving drug-course midway has become one of the biggest concerns in India.

Published
29 March 2011
From
Times of India
Treatment interruptions explain higher HIV viral load in patients with depression and those who use stimulants

Inconsistent use of antiretroviral therapy is the main explanation for the higher viral loads observed in HIV-positive patients who are depressed or who use stimulant drugs, US

Published
08 February 2011
By
Michael Carter
Breaks from HIV therapy still associated with poorer outcomes 8 years later

HIV-positive patients who take breaks from their antiretroviral therapy have poorer increases in their CD4 cell count, are more likely to develop HIV-related illness, and have a

Published
18 January 2011
By
Michael Carter
Even with antiretroviral treatment, patients with HIV still have markers indicating increased risk of heart disease and kidney problems

Key biomarkers associated with an increased risk of serious illnesses such as heart disease and kidney dysfunction are elevated in patients with HIV, even when

Published
19 May 2010
By
Michael Carter
Thrombocytopenia associated with treatment interruptions: HIV replication a cause

A quarter of patients interrupting antiretroviral therapy developed thrombocytopenia, French investigators report in the December 15th edition of the Journal of Acquired Immune Deficiency Syndromes. “Even

Published
12 January 2010
By
Michael Carter
‘Drug holidays’ best predictor of treatment failure, adherence studies find

Failure to take every dose on time is not a good guide to whether patients will fail their therapy, according to studies from several countries

Published
23 November 2009
By
Gus Cairns
Early treatment and interruption makes no difference to disease progression, study finds

The largest study yet done on the whether immediate antiretroviral therapy (ART) may benefit people with recent HIV infection has found that immediate treatment followed

Published
04 September 2009
By
Gus Cairns

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.